-PTI The UIDAI's Aadhaar project for providing unique identity numbers to residents, has huge potential to improve the delivery of social sector schemes like rural employment guarantee, the Economic Survey 2011-12 said. "Aadhaar has huge potential for improving operations and delivery of services," the survey said. The Unique Identification Authority of India (UIDAI), attached to the Planning Commission, is engaged in providing residents in the country a Unique Identification number (called Aadhaar) linked...

Census sheds new light on changing nation Though half of all Indians do not have a toilet at home, well over half own a telephone, new census data released on Tuesday show. These and many other contrasting facts of life have come out in Census 2011. The data on housing, household amenities and assets cast new light on a country in the throes of a complex transition, where millions have access to...

-The Hindu   Governments of all hues at the Center and state levels have always claimed to be working for uplift of dalits and tribals, two of the most deprived sections in India. Together, they comprise nearly a quarter of India's population. Yet progress has been slow and patchy despite decades of affirmative action. Why?  Part of the answer lies in gross neglect and insincerity of political rulers - this is the conclusion...

The Sonia Gandhi-led National Advisory Council (NAC) has released draft recommendations for a social security package for the country’s unorganized sector, which envisages providing life, disability and health cover, maternity benefits and old-age pension to workers. NAC, in a draft released on 7 March, suggested that the different welfare schemes being run by the ministries of women and child development, health and family welfare, finance and labour and employment should be...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...